Suppression of c-MET overcomes erlotinib resistance in tongue cancer cells
Keqiang Huang, Dongxu Liu Department of Orthodontics, School of Stomatology, Shandong University, Shandong Provincial Key Laboratory of Oral Tissue Regeneration, Jinan 250012, China Background: Erlotinib is a commonly used molecular-targeted drug for the treatment of tongue cancer. However, the de...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2018-09-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/suppression-of-c-met-overcomes-erlotinib-resistance-in-tongue-cancer-c-peer-reviewed-article-OTT |